Angiogenesis Assays Industry is expected to achieve US$ 5,112.2 Million by 2033, as per FMI’s research

The global angiogenesis assays industry in 2022 was US$ 1972.1 million and is estimated to be US$ 2,139.7 million in 2023. Future Market Insights has mentioned in its reports that the angiogenesis assays industry will expand at a CAGR of 9.10% between 2023 and 2033, totaling around US$ 5,112.2 million by 2033.

A boost in demand for angiogenesis assays in drug discovery, huge investments in research, and a rise in the number of drug discovery companies uplifts the growth of the global angiogenesis assay industry.

Request a Sample Copy of this research report! https://www.futuremarketinsights.com/reports/sample/rep-gb-10030

The surge in the usage of angiogenesis assay techniques for high screening methods like drug screening, in-vitro testing, etc has thus created new opportunities in the coming years.

Key Takeaways from the Market Study:

• Global angiogenesis assays industry grew at a CAGR of 7.3% between 2017 and 2022
• Global angiogenesis assay industry demand is anticipated to be valued at US$ 1,972.1 million in 2022, forecast to grow at a CAGR of 9% to be valued at US$ 4,650 million from 2022 to 2032
• North America holds the major share of the market, with a market share of 38.1%, and the United States factor is expected to accelerate the market growth with a market share of 43.0%.
• India is said to grow at a CAGR of 10.9% and China’s growth at a CAGR of 10.2% is anticipated to favor the growth of the angiogenesis assay market during the forecast period, attributed to the rising prevalence of the chronic diseases, and increasing cell-based studies in the region including Australia growing at a CAGR of 8.7% and Japan holding the value share of 5.3%.
• Europe is said to hold a market share of 29.3% after North America, where the United Kingdom and Germany are said to hold a major portion in this market where United Kingdom grows at a CAGR of 8.1% whereas Germany has a value share of 6.7%
• In-vitro angiogenesis application is said to be faring holds a market share of 63.0%
• Hospitals are considered to be the most in-demand hold a value share of 48.0% in this market
• Angiogenesis tube formation assays are said to hold a dominant position are said to hold a major market share of 52.3%

“Increase in the number of research and development activities is one of the major drivers of the angiogenesis assays market”, comments a Future Market Insights analyst

Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-10030

Competitive Analysis:

Some of the prominent players in the global market are-

• Cell Biolabs, Inc.
• Thermo Fisher Scientific
• Abcam plc.
• PromoCell GmbH
• Merck KGaA
• ATCC
• Corning Incorporated
• Bio-Techne
• Molecular Devices, LLC
• BioVision, Inc.

Some of the important developments of the key players in the market are:

• In February 2023, Innovative drugs often mean new treatment options for patients and advances in health care for the American public. When it comes the development of new drugs and therapeutic biological products, FDA’s Center for Drug Evaluation and Research (CDER) provides clarity to drug developers on the necessary study design elements and other data needed in the drug application to support a full and comprehensive assessment.
• In February 2023, Merck known as MSD outside of the United States and Canada, announced that it has reached an agreement to sell its 108-acre campus in Kenilworth, N.J., to Onyx Equities, LLC.

Elevate Your Brand: Explore the Insights from Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-10030

Key Segments Profiled in the Angiogenesis Assay Industry Survey:

Product Type:

• Angiogenesis Tube Formation Assays
• Microfluidic
• Endothelial Adhesion
• Invasion and Migration Assays

Application:

• In Vitro Angiogenesis
• In Vivo Angiogenesis

End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific excluding Japan
• China
• Japan
• Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube